Lifecome Biochemistry Co., Ltd.

Lifecome Biochemistry Co., Ltd. saw its stock price drop significantly today, contrasting with gains in the broader market. Despite a strong annual increase, the company has faced recent declines and challenges in profitability, reflected in low ROCE and negative ROE. Its market capitalization is CNY 5,648 million.

Lifecome Biochemistry Co., Ltd. saw a significant stock increase on February 26, 2026, reaching an intraday high. The company has demonstrated strong performance metrics, with substantial gains over the past year and year-to-date. However, challenges such as a negative book value and high debt-to-equity ratio may impact its long-term outlook.

Lifecome Biochemistry Co., Ltd. has demonstrated strong stock performance, gaining 5.01% on February 25, 2026, and achieving a notable annual increase of 137.29%. Despite this success, the company faces challenges such as a negative book value and a high debt-to-equity ratio, alongside fluctuating operating profits.